Axon (AXON) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Core Insights - Analysts forecast Axon Enterprise (AXON) to report quarterly earnings of $1.06 per share, reflecting a year-over-year decline of 4.5% and revenues of $476.92 million, which is an increase of 27.3% compared to the previous year [1] - There has been a downward revision of 3.6% in the consensus EPS estimate over the last 30 days, indicating a reconsideration of initial forecasts by analysts [1] Revenue Estimates - 'Net Sales- Software and Sensors' are expected to reach $296.36 million, showing a year-over-year increase of 34.6% [2] - 'Revenue- TASER' is projected at $180.71 million, indicating a change of +17% from the prior-year quarter [2] - 'Net Sales- Services- Software and Sensors' are forecasted to be $188.25 million, reflecting a year-over-year increase of 41.9% [2] Product Sales Estimates - 'Net Sales- Products- Software and Sensors' are anticipated to be $107.38 million, with a year-over-year change of +22.6% [3] - 'Net Sales- Products' are expected to reach $277.97 million, indicating a change of +19.1% from the previous year [3] - 'Net Sales- Services' are projected at $195.56 million, reflecting a year-over-year increase of 38.6% [3] - 'Net Sales- Products- TASER' are estimated to be $172.19 million, indicating a change of +18% from the prior-year quarter [3] - 'Net sales by Product- Software and Sensors segment- Axon Evidence and cloud services' are expected to be $189.07 million, reflecting a year-over-year change of +43.1% [3] Additional Sales Estimates - 'Net Sales- Services- TASER' are projected to reach $11.55 million, indicating a change of +35.9% from the prior-year quarter [4] - 'Net sales by Product- Software and Sensors segment- Axon Fleet' is estimated at $30.02 million, reflecting a decrease of 16.5% from the previous year [4] - 'Net sales by Product- Software and Sensors segment- Axon Body' is expected to be $52.79 million, indicating a year-over-year increase of 61.1% [4] - 'Net Sales- Products- TASER- Cartridges' are projected at $57.69 million, reflecting a change of +19.1% from the prior-year quarter [4] Stock Performance - Shares of Axon have experienced a change of +1.2% in the past month, compared to a +1.1% move of the Zacks S&P 500 composite [4]